SANRENO THERAPEUTICS
SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies in the People’s Republic of China, Hong Kong, Macau, Taiwan and Singapore (the “Territory”). SanReno Therapeutics formed with JV of Chinook Therapeutics and Frazier Healthcare Partners and Pivotal bioVenture Partners China.
SANRENO THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2020-01-01
Address:
Beijing, Beijing, China
Country:
China
Status:
Active
Total Funding:
40 M USD
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Funding Round - SanReno Therapeutics
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Funding Round - SanReno Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Funding Round - SanReno Therapeutics
Versant Ventures
Versant Ventures investment in Funding Round - SanReno Therapeutics